These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1995491)

  • 1. Tumor regression and induction of anti-tumor immunity by local chemotherapy of guinea-pigs bearing a line-10 hepatocarcinoma.
    Claessen AM; Valster H; Bril H; Steerenberg PA; Tan BT; Scheper RJ
    Int J Cancer; 1991 Feb; 47(4):626-32. PubMed ID: 1995491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local administration of cytostatic drug 4-hydroperoxy-cyclophosphamide (4-HPCY) facilitates cell-mediated immune reactions.
    Boerrigter GH; Scheper RJ
    Clin Exp Immunol; 1984 Oct; 58(1):161-6. PubMed ID: 6478648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional administration of etoposide, but not of interleukin 2, facilitates active specific immunization in guinea pigs with advanced carcinoma.
    Claessen AM; Bloemena E; Bril H; Meijer CJ; Scheper RJ
    Cancer Res; 1992 May; 52(9):2440-6. PubMed ID: 1568214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of various cytostatic drugs as local immunotherapeutic agents.
    Scheper RJ; Vos A; de Groot J; Boerrigter GH
    Invest New Drugs; 1984; 2(2):221-5. PubMed ID: 6332093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEG-IL-2 therapy of advanced cancer in the guinea pig. Impact of the primary tumor and beneficial effect of cyclophosphamide.
    Balemans LT; Steerenberg PA; Koppenhagen FJ; Kremer BH; De Mulder PH; Claessen AM; Scheper RJ; Den Otter W
    Int J Cancer; 1994 Sep; 58(6):871-6. PubMed ID: 7927881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradermal administration of 4-hydroperoxy-cyclophosphamide during contact sensitization potentiates effector T cell responsiveness in draining lymph nodes.
    Boerrigter GH; de Groot J; Scheper RJ
    Immunopharmacology; 1986 Feb; 11(1):13-20. PubMed ID: 3485619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immunity is enhanced by cytostatic drugs continuously released at the site of antigenic stimulation.
    Claessen AM; Valster H; Bril H; Meyer S; Scheper RJ
    Cancer Immunol Immunother; 1989; 28(2):131-5. PubMed ID: 2917364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local administration of cytostatic drugs enhances delayed-type hypersensitivity to Sendai virus in mice.
    Limpens J; Garssen J; Scheper RJ
    Clin Immunol Immunopathol; 1990 Jan; 54(1):161-5. PubMed ID: 2152858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional therapy with polyethylene-glycol-modified interleukin-2 of an intradermally growing hepatocellular carcinoma in the guinea pig induces T-cell-mediated antitumor activity.
    Balemans LT; Mattijssen V; Steerenberg PA; Van Driel BE; De Mulder PH; Den Otter W
    Cancer Immunol Immunother; 1993 Jul; 37(1):7-14. PubMed ID: 8513455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
    de Jong WH; van de Plas MM; Steerenberg PA; Kruizinga W; Ruitenberg EJ
    J Immunol; 1985 Mar; 134(3):2032-40. PubMed ID: 2578526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ; Kataoka T; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer.
    Key ME; Brandhorst JS; Hanna MG
    J Immunol; 1983 Jun; 130(6):2987-92. PubMed ID: 6304194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell involvement in adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
    de Jong WH; Steerenberg PA; van de Plas MM; Kruizinga W; Ruitenberg J
    J Natl Cancer Inst; 1985 Sep; 75(3):483-9. PubMed ID: 3875751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapeutic effects of local chemotherapy with an active metabolite of cyclophosphamide.
    Scheper RJ; Limpens J; Tan BT; Valster H; Claessen AM; Claessen ME
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):611-5. PubMed ID: 3325717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced induction of tumor-specific Lyt-1+2- T cell-mediated protective immunity by in vivo administration of interleukin 1.
    Izumi Y; Tsuchida T; Okuno K; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1985 Sep; 76(9):863-70. PubMed ID: 3932286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major histocompatibility complex class II antigen expression during potentiation of line-10 tumor immunity after intralesional administration of bacillus Calmette-Guérin.
    Steerenberg PA; De Jong WH; Geerse E; Aleva BJ; Besselink CM; Van Rens BT; Rutten VP; Poels LG; Scheper RJ; Den Otter W
    Cancer Immunol Immunother; 1990; 32(2):95-104. PubMed ID: 1963114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing effects of locally administered cytostatic drugs on T effector cell functions in mice.
    Limpens J; Garssen J; Germeraad WT; Scheper RJ
    Int J Immunopharmacol; 1990; 12(1):77-88. PubMed ID: 2303320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete regression of a guinea pig hepatocarcinoma by immunotherapy with "tumor-immune" RNA or antibody to fibrin fragment E.
    Schlager SI; Dray S
    Isr J Med Sci; 1976; 12(4-5):344-59. PubMed ID: 181352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site.
    Limpens J; Scheper RJ
    Clin Exp Immunol; 1991 Jun; 84(3):383-8. PubMed ID: 1828396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in dendritic cell phenotype and function associated with immunoenhancing effects of a subcutaneously administered cyclophosphamide derivative.
    Limpens J; Van Meijer M; Van Santen HM; Germeraad WT; Hoeben-Schornagel K; Breel M; Scheper RJ; Kraal G
    Immunology; 1991 Jul; 73(3):255-63. PubMed ID: 1879874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.